EXAI
Exscientia plc
Exchange: nyse
Multiples
- P/E:
- P/BV:
- P/TBV:
Description:
EXAI Therapeutics Inc. (ticker: EXAI) is a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on developing innovative treatments for cancer and inflammatory diseases by leveraging its proprietary artificial intelligence platform to identify new drug targets and therapeutic pathways. EXAI aims to accelerate the discovery process in pharmaceutical research, bringing potentially transformative medicines to patients more efficiently than traditional methods. Investors interested in biotech innovation and AI-driven drug development can consider EXAI as a key player in the sector.
Data:
Yields:
